Target intelligence / Profile preview

Macrophage polarization pathways

Molecular classification
Other
01

Overview

Macrophage polarization pathways represent the complex signaling networks that dictate the functional plasticity of macrophages in response to environmental stimuli [PMID: 24445666]. Macrophages can be polarized into two main phenotypes: the classically activated M1 phenotype, which is pro-inflammatory and microbicidal, and the alternatively activated M2 phenotype, which promotes anti-inflammatory responses and tissue repair [PMID: 25870903]. This process is regulated by key transcription factors such as STAT1 and NF-κB for M1, and STAT6, STAT3, and PPARγ for M2 [PMID: 25870903]. In many diseases, an imbalance in polarization occurs; for example, tumor-associated macrophages (TAMs) often adopt an M2-like state that supports tumor growth and suppresses the immune system [PMID: 28263170]. Therapeutic strategies aim to modulate these pathways to re-polarize macrophages, such as using CSF1R inhibitors or TLR agonists to convert pro-tumoral M2 macrophages into anti-tumoral M1 cells [PMID: 31015324]. Because Macrophage polarization pathways refers to a biological process rather than a single protein, it is considered a pathway-level target rather than a discrete molecular target.

Other names
M1/M2 polarizationMacrophage activation pathwaysMacrophage phenotypic switching
02

Mechanism of action

Modulation of intracellular signaling cascades (e.g., JAK/STAT, NF-kB, PI3K) and surface receptors (e.g., TLRs, CSF1R) to shift macrophage functional states between pro-inflammatory (M1) and anti-inflammatory/pro-repair (M2) phenotypes.

03

Biological functions

Immune responseInflammationTissue remodelingPhagocytosisWound healing
04

Disease associations

CancerInflammationAutoimmune diseaseAtherosclerosisFibrosis
05

Safety considerations

Systemic immunosuppressionCytokine release syndromeImpaired tissue repairOff-target myeloid toxicityPeriorbital edema
06

Interacting drugs

Pexidartinib

4 more in the full profile.

07

Biomarkers

CD80CD86iNOS (NOS2)CD163CD206 (MRC1)Arginase-1 (ARG1)IL-12IL-10

Beyond the preview

Go deeper on Macrophage polarization pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Macrophage polarization pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call